tetrabenazine has been researched along with Atherosclerotic Parkinsonism in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Akbar, U; Friedman, JH; Kim, DS | 1 |
| Akbostanci, MC; Sahin, T; Yilmaz, R | 1 |
| Bassett, AS; Boot, E; Butcher, NJ; Chow, EWC; Christopher, L; Fritsch, R; Lang, AE; Marras, C; Masellis, M; Pondal, M; Repetto, GM; Rusjan, P; Strafella, AP | 1 |
| Chang, CC; Chang, WN; Chang, YY; Hsiao, IT; Hsieh, CJ; Huang, CW; Huang, SH; Lin, KJ; Lui, CC; Yen, TC | 1 |
| Chan, MH; Chao, KT; Chen, ZA; Ee, TW; Hsiao, IT; Hsu, CH; Kung, MP; Lin, KJ; Weng, CC; Wey, SP; Yen, TC | 1 |
| Guay, DR | 1 |
| Fahn, S | 1 |
| Barraquer-Bordas, L; Kulisevsky, J; Lima de Freitas, M | 1 |
| Giladi, N; Melamed, E | 1 |
| Agid, Y; Darchen, F; Desnos, C; Javoy-Agid, F; Pollak, P; Scherman, D | 1 |
| Casabona, J; Jankovic, J | 1 |
| Moss, JH; Stewart, DE | 1 |
| Jankovic, J; Orman, J | 1 |
| Chalmers, RJ; Johnson, RH; McLellan, DL | 1 |
| Pakkenberg, H | 1 |
| Chase, TN | 1 |
| Fog, R; Pakkenberg, H | 1 |
2 review(s) available for tetrabenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Depression; Dopamine; Drug Interactions; Genotype; Humans; Huntington Disease; Hyperkinesis; Middle Aged; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Quinolizines; Reserpine; Serotonin; Tetrabenazine; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extrapyramidal Tracts; Fenclonine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Imipramine; Levodopa; Muscular Diseases; Paralysis; Parkinson Disease; Parkinson Disease, Secondary; Probenecid; Reserpine; Serotonin; Spinal Cord Diseases; Tetrabenazine; Time Factors | 1974 |
4 trial(s) available for tetrabenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
¹⁸F-FP-(+)-DTBZ positron emission tomography detection of monoaminergic deficient network in patients with carbon monoxide related parkinsonism.
Topics: Adult; Biogenic Monoamines; Carbon Monoxide Poisoning; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Positron-Emission Tomography; Severity of Illness Index; Tetrabenazine; White Matter | 2015 |
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
Topics: Chorea; Clinical Trials as Topic; Drug Synergism; Dystonia; Humans; Lithium; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease, Secondary; Tetrabenazine; Tic Disorders | 1988 |
A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea.
Topics: Adult; Clinical Trials as Topic; Diseases in Twins; Dopamine; Drug Evaluation; Female; Homovanillic Acid; Humans; Huntington Disease; Male; Middle Aged; Neurologic Manifestations; Neurotic Disorders; Parkinson Disease, Secondary; Phenothiazines; Placebos; Serotonin; Tetrabenazine | 1974 |
Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mouth Diseases; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Remission, Spontaneous; Salivary Gland Diseases; Tetrabenazine; Time Factors | 1974 |
11 other study(ies) available for tetrabenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Valbenazine-induced parkinsonism.
Topics: Adrenergic Uptake Inhibitors; Adult; Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Female; Humans; Male; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2020 |
Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Chorea; Drug-Related Side Effects and Adverse Reactions; Dystonic Disorders; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Tic Disorders; Turkey; Young Adult | 2020 |
Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Topics: Adult; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; DiGeorge Syndrome; Female; Functional Neuroimaging; Humans; Hypertrophy; Male; Parkinson Disease, Secondary; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine; Ultrasonography, Doppler, Transcranial | 2017 |
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biphenyl Compounds; Corpus Striatum; Disease Models, Animal; Fluorine Radioisotopes; Humans; Lignans; Mice; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
Topics: Adult; Aged; alpha-Methyltyrosine; Carbidopa; Dopamine; Dopamine Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reserpine; Synapses; Tetrabenazine | 1983 |
Bilateral akinesia in drug-induced parkinsonism after a subthalamic lesion.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Hematoma; Humans; Neurologic Examination; Parkinson Disease, Secondary; Tetrabenazine; Thalamic Diseases; Thalamic Nuclei; Tomography, X-Ray Computed | 1994 |
Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.
Topics: Aged; Antiparkinson Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Recurrence; Sulpiride; Tetrabenazine | 1999 |
Striatal dopamine deficiency in Parkinson's disease: role of aging.
Topics: Aged; Aging; Corpus Striatum; Dopamine; Humans; Parkinson Disease, Secondary; Tetrabenazine | 1989 |
Coexistent tardive dyskinesia and parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reserpine; Tetrabenazine | 1987 |
Iatrogenic parkinsonism in Huntington's chorea.
Topics: Chlorpromazine; Drug Interactions; Female; Humans; Huntington Disease; Middle Aged; Parkinson Disease, Secondary; Tetrabenazine | 1986 |
The effect of tetrabenazine in some hyperkinetic syndromes.
Topics: Adult; Age Factors; Aged; Facial Nerve; Humans; Huntington Disease; Hyperkinesis; Mastication; Middle Aged; Parkinson Disease, Secondary; Tetrabenazine | 1968 |